These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 10918581)
21. Deletion of the pleckstrin and phosphotyrosine binding domains of insulin receptor substrate-2 does not impair its ability to regulate cell proliferation in myeloid cells. Sun H; Baserga R Endocrinology; 2004 Nov; 145(11):5332-43. PubMed ID: 15297443 [TBL] [Abstract][Full Text] [Related]
22. IL-3 and IL-4 activate cyclic nucleotide phosphodiesterases 3 (PDE3) and 4 (PDE4) by different mechanisms in FDCP2 myeloid cells. Ahmad F; Gao G; Wang LM; Landstrom TR; Degerman E; Pierce JH; Manganiello VC J Immunol; 1999 Apr; 162(8):4864-75. PubMed ID: 10202031 [TBL] [Abstract][Full Text] [Related]
23. Constitutive NF-kappaB DNA-binding activity in AML is frequently mediated by a Ras/PI3-K/PKB-dependent pathway. Birkenkamp KU; Geugien M; Schepers H; Westra J; Lemmink HH; Vellenga E Leukemia; 2004 Jan; 18(1):103-12. PubMed ID: 14574326 [TBL] [Abstract][Full Text] [Related]
24. The peripheral cannabinoid receptor Cb2, a novel oncoprotein, induces a reversible block in neutrophilic differentiation. Jordà MA; Lowenberg B; Delwel R Blood; 2003 Feb; 101(4):1336-43. PubMed ID: 12406867 [TBL] [Abstract][Full Text] [Related]
27. Phosphatidylinositol 3-kinase and Ras/mitogen-activated protein kinase signaling pathways are required for the regulation of 5-aminolevulinate synthase gene expression by insulin. Scassa ME; Guberman AS; Varone CL; Cánepa ET Exp Cell Res; 2001 Dec; 271(2):201-13. PubMed ID: 11716532 [TBL] [Abstract][Full Text] [Related]
28. Insulin-like growth factor I-mediated protection from rapamycin-induced apoptosis is independent of Ras-Erk1-Erk2 and phosphatidylinositol 3'-kinase-Akt signaling pathways. Thimmaiah KN; Easton J; Huang S; Veverka KA; Germain GS; Harwood FC; Houghton PJ Cancer Res; 2003 Jan; 63(2):364-74. PubMed ID: 12543789 [TBL] [Abstract][Full Text] [Related]
29. Signalling pathways of insulin-like growth factor-I that are augmented by cAMP in FRTL-5 cells. Ariga M; Nedachi T; Akahori M; Sakamoto H; Ito Y; Hakuno F; Takahashi S Biochem J; 2000 Jun; 348 Pt 2(Pt 2):409-16. PubMed ID: 10816436 [TBL] [Abstract][Full Text] [Related]
30. Changes in the mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling associated with the induction of apoptosis. Marushige K; Marushige Y Anticancer Res; 1999; 19(5B):3865-71. PubMed ID: 10628325 [TBL] [Abstract][Full Text] [Related]
31. Alteration of growth and differentiation factors response by Kirsten and Harvey sarcoma viruses in the IL-3-dependent murine hematopoietic cell line 32D C13(G). Mavilio F; Kreider BL; Valtieri M; Naso G; Shirsat N; Venturelli D; Reddy EP; Rovera G Oncogene; 1989 Mar; 4(3):301-8. PubMed ID: 2468124 [TBL] [Abstract][Full Text] [Related]
32. Differential modulation of the tyrosine phosphorylation state of the insulin receptor by IRS (insulin receptor subunit) proteins. Solow BT; Harada S; Goldstein BJ; Smith JA; White MF; Jarett L Mol Endocrinol; 1999 Oct; 13(10):1784-98. PubMed ID: 10517679 [TBL] [Abstract][Full Text] [Related]
33. Identification of signal transduction pathways involved in constitutive NF-kappaB activation in breast cancer cells. Bhat-Nakshatri P; Sweeney CJ; Nakshatri H Oncogene; 2002 Mar; 21(13):2066-78. PubMed ID: 11960379 [TBL] [Abstract][Full Text] [Related]
34. The downregulation of the pro-apoptotic protein Par-4 is critical for Ras-induced survival and tumor progression. Barradas M; Monjas A; Diaz-Meco MT; Serrano M; Moscat J EMBO J; 1999 Nov; 18(22):6362-9. PubMed ID: 10562548 [TBL] [Abstract][Full Text] [Related]
35. Binding activity of H-Ras is necessary for in vivo inhibition of ASK1 activity. Du J; Cai SH; Shi Z; Nagase F Cell Res; 2004 Apr; 14(2):148-54. PubMed ID: 15115616 [TBL] [Abstract][Full Text] [Related]
36. Differential regulation of insulin receptor substrate-2 and mitogen-activated protein kinase tyrosine phosphorylation by phosphatidylinositol 3-kinase inhibitors in SH-SY5Y human neuroblastoma cells. Kim B; Leventhal PS; White MF; Feldman EL Endocrinology; 1998 Dec; 139(12):4881-9. PubMed ID: 9832424 [TBL] [Abstract][Full Text] [Related]
37. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways. Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018 [TBL] [Abstract][Full Text] [Related]
38. Radicicol suppresses transformation and restores tropomyosin-2 expression in both ras- and MEK-transformed cells without inhibiting the Raf/MEK/ERK signaling cascade. Kim PN; Jonasch E; Mosterman BC; Mier JW; Janssen RA Cell Growth Differ; 2001 Nov; 12(11):543-50. PubMed ID: 11714635 [TBL] [Abstract][Full Text] [Related]
39. Expression of human TFF3 in relation to growth of HT-29 cell subpopulations: involvement of PI3-K but not STAT6. Durual S; Blanchard C; Estienne M; Jacquier MF; Cuber JC; Perrot V; Laboisse C; Cuber JC Differentiation; 2005 Feb; 73(1):36-44. PubMed ID: 15733066 [TBL] [Abstract][Full Text] [Related]
40. Prevention of v-Ha-Ras-dependent apoptosis by PDGF coordinates in phosphorylation of ERK and Akt. Arase Y; Hiwasa T; Hasegawa R; Nomura J; Ito H; Suzuki N Biochem Biophys Res Commun; 2000 Jan; 267(1):33-9. PubMed ID: 10623570 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]